carnitine has been researched along with Propofol Infusion Syndrome in 1 studies
Propofol Infusion Syndrome: Rare and often fatal drug complication which affects patients undergoing long-term treatment with high doses of PROPOFOL. It is characterized by METABOLIC ACIDOSIS; HYPERLIPIDEMIA; RHABDOMYOLYSIS; cardiovascular CIRCULATORY COLLAPSE; CARDIAC FAILURE; and KIDNEY FAILURE.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vollmer, JP | 1 |
| Haen, S | 1 |
| Wolburg, H | 1 |
| Lehmann, R | 1 |
| Steiner, J | 1 |
| Reddersen, S | 1 |
| Fend, F | 1 |
| Fallier-Becker, P | 1 |
1 other study available for carnitine and Propofol Infusion Syndrome
| Article | Year |
|---|---|
Propofol Related Infusion Syndrome: Ultrastructural Evidence for a Mitochondrial Disorder.
Topics: Carnitine; Craniotomy; Hematoma, Subdural, Intracranial; Humans; Infusions, Intravenous; Male; Micro | 2018 |